SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (1604)11/5/1998 8:19:00 PM
From: Steve Harmon   of 2742
 
John de C,

Where CIST is trading is not the problem here. Similiar manipulation occurs on the Nasdaq regular and small cap also.

Reverse splits are a way for inept management to cover up stupid financing deals...Look at SPTA and PRCT for recent reverse splits that tanked back to under a buck after the reverse occurred.

It is very obvious what has occurred in the last two years at Cistron...It is what i have dubbed over the years as BIOTECH CEO WELFARE.

A stock buyback which matches what the 2 officers left at Cistron would very easily support Cistron's stock at much higher levels. Not doing one ALLOWS our shares to trade at pathetic levels.

Steve

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext